Recently, we have been featured in an Insider article highlighting VCs investing in medical psychedelics and contributed to an article featuring the top companies in the space. Read the articles via the links below! Insider lnkd.in/eqNibZt7 lnkd.in/eeifnEpZ

It was great to be able to contribute to the below piece and share our thoughts on the future of psychedelic startups and the sector in general. Click on the link below to read the full article! TechCrunch #medicalpsychedelics techcrunch.com/2023/05/12/psy…

Tetra Pharm Technologies, a portfolio company of the fund, received promising results from preclinical testing of TPT0301 (its pain-relieving drug). Click on the link below to learn more! prnewswire.co.uk/news-releases/…

The fund’s portfolio company, Tactogen, was recently mentioned in a New York Times piece! Click on the link below to read the full article. Tactogen #tactogen #alternativemedicine #VentureCapital nytimes.com/2023/08/18/wel…

Tetra Pharm Technologies, one of the fund's portfolio companies, has successfully completed preclinical testing of TPT0301 ahead of the first-in-human clinical trials. Click on the link below to learn more! #alternativemedicine #venturecapital prnewswire.com/news-releases/…

This week, Tactogen, a portfolio company of the fund, announced the granting of its U.S. patent that covers MDMA analogues. This is the first U.S. patent awarded for novel psychoactive MDMA derivatives! Click on the link below to find out more. tactogen.com/news/#patent

Our fund portfolio company, Ceretype Neuromedicine, has successfully raised its second seed round of over US$2M to further its effort of making fMRI more accessible and delivering actionable evidence to improve drug discovery as well as patient care! businesswire.com/news/home/2024…

Our Principal, Andrey, will be speaking at Cannabis Invest UK on the 31st of January 2024 in London. If you are interested in attending and would like to receive 50% off event passes, please use the code 'Friends' at bloompoint.co.uk/event-info/can…. Bloom Analytic Gowling WLG

Looking forward to having our Principal, Andrey, speaking on “German Cannabis declassification – a new era for patient access” at Cannabis Invest UK in London tomorrow! For last-minute event passes, use the code 'Friends' at lnkd.in/dk9u_Hhz to get 50% off.

Germany has officially passed its cannabis legalisation bill. This marks an important milestone for the European cannabis sector, and we believe will set a strong precedent for other EU member states to follow! Click on the link below to learn more. businessofcannabis.com/germanys-canna…

The fund’s portfolio company, Beckley Psytech, announced positive initial data from its Phase IIa study pertaining to the use of BPL-003 for Treatment-Resistant Depression, which further boosts confidence in the company’s Phase IIb study. Learn more below! beckleypsytech.com/posts/beckley-…